Third-Party vs Contract vs Loan Licensing vs CDMO: What the Terms Actually Mean

Third-party manufacturing. Contract manufacturing. Loan licensing. P2P. CDMO. Toll manufacturing. In Indian pharma these get used as if they mean the same thing, and they mostly do — except when they do not, and the difference decides whose licence your product is made under and who carries the blame if a batch fails.

Here is what each term actually means, in practice, in this industry.

Third-party manufacturing

The everyday Indian term. A licensed manufacturer produces medicine for you, at their plant, under their drug licence, packed under your brand. Their licence number and site address are printed on your pack.

You own the brand and the market. They own the plant, the licence, the compliance and batch quality. This is what most people mean by every term on this page, and it is what most of the industry actually runs on.

Contract manufacturing

The formal term for the same arrangement. If someone says contract manufacturing and someone else says third-party manufacturing, in India they are almost always describing the identical thing. Contract manufacturing tends to be used for larger, longer arrangements and in international contexts; third-party is what people say on the phone.

Loan licensing — this one is genuinely different

Here the arrangement inverts. Under a loan licence, you hold a manufacturing licence for a plant you do not own — you borrow the facility. The product is made on your licence, using their premises and equipment.

The practical consequence: the regulatory responsibility is yours, not theirs. Under third-party manufacturing, the manufacturer's site certificate makes batch quality their obligation. Under a loan licence, you hold the licence, so you hold the exposure.

Most people asking for "third-party manufacturing" do not want a loan licence and should not agree to one by accident. Ask which arrangement you are actually signing.

P2P (principal-to-principal)

A commercial framing rather than a regulatory one. Both parties deal as independent businesses: they sell you finished goods, you buy them. It usually describes the same physical arrangement as third-party manufacturing, with the emphasis on a clean sale rather than a service.

Toll manufacturing

Strictly, the customer supplies the raw material and pays the manufacturer a "toll" to convert it. In Indian pharma the manufacturer almost always sources the API, so true toll arrangements are uncommon — the term gets borrowed loosely for contract manufacturing generally.

CDMO

Contract Development and Manufacturing Organisation. The difference is the D. A CDMO does not only make what you specify — it develops the formulation, runs the analytical work, does the stability studies, and then manufactures. If you have a molecule and no formulation, you want development. If you want a known combination made under your brand, you want plain contract manufacturing, and paying for CDMO capability is paying for something you will not use.

PCD franchise — not manufacturing at all

Included because it is constantly confused with the rest. In a PCD pharma franchise you do not own a brand and do not commission production. You sell an existing company's brands in a monopoly territory. No batch, no trademark, no artwork, no forecast.

Manufacturing suits people building their own brand. Franchise suits people who want to start selling without creating products. Many operators do both — franchise for breadth, own brands on their strongest molecules.

The only distinction that changes your risk

Ignore the vocabulary. Ask one question: whose drug licence is my product manufactured under?

• Theirs — third-party, contract, P2P, toll, CDMO. Batch quality is legally the manufacturer's, as stated on their site certificate.
• Yours — loan licence. The exposure is yours.

Everything else on this page is vocabulary. That question is the arrangement.

Who manufactures for Vibcare

Vibcare Pharma is a PCD pharma franchise company. It does not manufacture. Manufacturing is done by Vibcare Healthcare Private Limited — a separate company under the same ownership, with its own plant, licences and website.

The site: Khasra No. 6/2/2, Kota Road, Dabkori, Panchkula 134103, Haryana. WHO-GMP certified by the State Drugs Controller-cum-Licensing Authority, FDA Haryana. Site Certificate No. 1/182-1Drug-I-2024, issued 24 October 2024. Licences MLF252023HR000004 and MLF282023HR000005, valid to 7 May 2028. 100,000 sq ft clean room, 750+ drug approvals.

Certified for four dosage forms: tablets, capsules and external preparations — all non beta-lactam — and oral liquids. It does not make beta-lactam antibiotics, ophthalmics, injectables, softgels, IV liquids, respules, DPI, nasal sprays, protein powders and sachets, or ayurvedic products, because it is not certified for them.

Want the franchise route instead? A PCD pharma franchise — monopoly territory, ready range, from ₹25,000, no manufacturing arrangement of any kind. Here is the difference.

Frequently asked questions

What is 3rd party manufacturing in the pharmaceutical industry?

An arrangement where a licensed manufacturer produces medicine at their plant, under their drug licence, packed under your brand name. Their licence number and site address appear on your pack. You own the brand and the market; they own the plant, the compliance and legal responsibility for batch quality.

What is the difference between third-party manufacturing and loan licensing?

In third-party manufacturing the product is made under the manufacturer's licence, so batch quality is legally their responsibility. Under a loan licence you hold a manufacturing licence for a plant you do not own, so the regulatory exposure is yours. Most people asking for third-party manufacturing should not sign a loan licence by accident.

Is contract manufacturing the same as third-party manufacturing?

In India, effectively yes. Contract manufacturing is the formal term, used more for larger or international arrangements; third-party manufacturing is what people say day to day. Both describe production at someone else's licensed plant under your brand name.

What is the difference between a CDMO and a contract manufacturer?

The D — development. A CDMO develops the formulation, runs analytical and stability work, then manufactures. A contract manufacturer makes a known formulation to your specification. If you have a molecule and no formulation you need development; if you want a known combination under your brand, you are paying for capability you will not use.